Zobrazeno 1 - 9
of 9
pro vyhledávání: '"I. Chaffai"'
Publikováno v:
Cancer/Radiothérapie. 26:542-546
Resume Objectif de l’etude La radiotherapie hypofractionnee moderee est devenue une pratique de routine pour une population selectionnee de patientes traitees pour un cancer du sein de stade precoce. En avril 2020 est publiee l’etude Fast Forward
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::773a911c0911039a445f67d5ae5b461b
https://doi.org/10.1016/j.canrad.2021.07.036
https://doi.org/10.1016/j.canrad.2021.07.036
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 26(4)
Moderate hypofractionated radiotherapy has become routine practice for a selected population of patients treated for early-stage breast cancer. In April 2020, the Fast Forward (FF) study was published which introduced another extreme hypofractionated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a1fc0a17b45561891c90921a2628548a
https://pubmed.ncbi.nlm.nih.gov/34454837
https://pubmed.ncbi.nlm.nih.gov/34454837
Autor:
I. Chaffai, M. Boukhris, Leila Farhat, Samir Kammoun, F. Dhouib, Wafa Mnejja, Leila Abid, Jamel Daoud, Nejla Fourati, Selma Charfeddine
Publikováno v:
International journal of cardiology. 345
Background Cardiotoxicity following breast cancer radiotherapy (RT) represents one of the most redoubtable toxicities. The Global longitudinal strain measurement (GLS) based on 2D speckle tracking imaging (STI) allows detection of left ventricular (L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fdb63aae4cc08e719f9bea4f9a6c7c0
https://pubmed.ncbi.nlm.nih.gov/34998945
https://pubmed.ncbi.nlm.nih.gov/34998945
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 13:255
Introduction Cardiotoxicity following breast cancer radiotherapy (RT) is one of the major side effects. The Global longitudinal strain measurement (GLS) based on 2D speckle tracking imaging (STI) allows detection of left ventricular (LV) dysfunction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::477c0e7d88622b2dbe9c440da02ceec9
https://doi.org/10.1016/j.acvdsp.2021.04.039
https://doi.org/10.1016/j.acvdsp.2021.04.039
Autor:
W. Siala, I. Chaffai, Nejla Fourati, A. Hdiji, M. Kallel, Wafa Mnejja, J. Daoud, Leila Farhat
Publikováno v:
Cancer/Radiothérapie. 22:713-714
Objectif de l’etude Evaluer les doses recues, par le foie au cours de la radiotherapie conformationnelle du cancer du sein droit. Materiel et methode Etude dosimetrique retrospective ayant repris le plan de traitement de 63 patientes ayant recu une
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f3fc88308bcce8511f70f568b4aac17
https://doi.org/10.1016/j.canrad.2018.07.057
https://doi.org/10.1016/j.canrad.2018.07.057
Autor:
J. Daoud, Wafa Mnejja, I. Chaffai, H. Daoud, A. Hdiji, F. Ajengui, Leila Farhat, M. Kallel, Nejla Fourati
Publikováno v:
Cancer/Radiothérapie. 22:717
Objectif de l’etude Evaluer la dose recue par la moelle epiniere lors d’irradiation mammaire. Materiel et methode Etude retrospective menee entre 2016 et 2017 et colligeant les donnees de 145 patientes atteintes d’un carcinome mammaire traite p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75e41dd58d12e3d9b36d5f10c90147ff
https://doi.org/10.1016/j.canrad.2018.07.065
https://doi.org/10.1016/j.canrad.2018.07.065
Autor:
Ba MB; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Giudici F; Bureau de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018, Inserm, Paris-Saclay University, F-94805, Villejuif, France., Bellini C; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Auzac G; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Louvel G; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Bockel S; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Moukasse Y; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Chaffai I; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Berthelot K; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Vatonne A; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Conversano A; Gustave Roussy, Surgery Department, F-94805, Villejuif, France., Viansone A; Gustave Roussy, Medical Oncology Department, F-94805, Villejuif, France., Larue C; Bureau de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018, Inserm, Paris-Saclay University, F-94805, Villejuif, France., Deutsch E; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France; Université Paris-Saclay, Gustave Roussy, Inserm 1030, 94805, Villejuif, France., Michiels S; Bureau de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018, Inserm, Paris-Saclay University, F-94805, Villejuif, France., Milewski C; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France., Rivera S; Gustave Roussy, Radiation Therapy Department, F-94805, Villejuif, France; Université Paris-Saclay, Gustave Roussy, Inserm 1030, 94805, Villejuif, France. Electronic address: sofia.rivera@gustaveroussy.fr.
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2024 Sep; Vol. 36 (9), pp. e333-e341. Date of Electronic Publication: 2024 Jun 15.
Autor:
Sun R; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France., Henry T; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France.; Department of Nuclear Medicine, Gustave Roussy, Villejuif, France., Laville A; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France., Carré A; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France., Hamaoui A; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France., Bockel S; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France., Chaffai I; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France., Levy A; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France., Chargari C; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France.; Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy, Villejuif, France., Robert C; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France., Deutsch E; Department of Radiation Oncology, Gustave Roussy, Villejuif, France eric.deutsch@gustaveroussy.fr.; Radiothérapie Moléculaire et Innovation Thérapeutique, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France.; INSERM U1030, Gustave Roussy, Villejuif, France.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jul; Vol. 10 (7).
Autor:
Fourati N; Radiotherapy Department, Habib Bourguiba Hospital, Medical School University of Sfax, Sfax, Tunisia; Research Laboratory Medical Oncology and Oncology Radiotherapy LR19ES14, Tunisia. Electronic address: nejla_fourati@yahoo.fr., Charfeddine S; Cardiology Department, Hedi Chaker Hospital, Medical School University of Sfax, Sfax, Tunisia; Research Unity of Heart Failure UR17ES37, Tunisia., Chaffai I; Radiotherapy Department, Habib Bourguiba Hospital, Medical School University of Sfax, Sfax, Tunisia; Research Laboratory Medical Oncology and Oncology Radiotherapy LR19ES14, Tunisia., Dhouib F; Radiotherapy Department, Habib Bourguiba Hospital, Medical School University of Sfax, Sfax, Tunisia; Research Laboratory Medical Oncology and Oncology Radiotherapy LR19ES14, Tunisia., Farhat L; Radiotherapy Department, Habib Bourguiba Hospital, Medical School University of Sfax, Sfax, Tunisia; Research Laboratory Medical Oncology and Oncology Radiotherapy LR19ES14, Tunisia., Boukhris M; Cardiology Division, Hospital Center University of Montreal, Quebec, Canada., Abid L; Cardiology Department, Hedi Chaker Hospital, Medical School University of Sfax, Sfax, Tunisia; Research Unity of Heart Failure UR17ES37, Tunisia., Kammoun S; Cardiology Department, Hedi Chaker Hospital, Medical School University of Sfax, Sfax, Tunisia; Research Unity of Heart Failure UR17ES37, Tunisia., Mnejja W; Radiotherapy Department, Habib Bourguiba Hospital, Medical School University of Sfax, Sfax, Tunisia; Research Laboratory Medical Oncology and Oncology Radiotherapy LR19ES14, Tunisia., Daoud J; Radiotherapy Department, Habib Bourguiba Hospital, Medical School University of Sfax, Sfax, Tunisia; Research Laboratory Medical Oncology and Oncology Radiotherapy LR19ES14, Tunisia.
Publikováno v:
International journal of cardiology [Int J Cardiol] 2021 Dec 15; Vol. 345, pp. 130-136. Date of Electronic Publication: 2021 Oct 20.